Paraneoplastic dermatomyositis: a case report from North-East India
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20203760Keywords:
Paraneoplastic, Dermatomyositis, Nasopharyngeal carcinomaAbstract
Dermatomyositis is a rare autoimmune myopathy with distinctive cutaneous changes. It has been associated with a wide range of malignancies like carcinoma ovary, lung, breast, gastrointestinal tract and non-Hodgkin’s lymphoma. The malignancy can be concurrent or can occur before or after the onset of myositis. We report a case of dermatomyositis in a 63-year-old Indian male with nasopharyngeal carcinoma. The characteristic cutaneous features and muscle weakness developed concomitantly with the onset of nasopharyngeal carcinoma.
Metrics
References
Shy GM. The late onset myopathy: a clinicopathologic study of 131 patients. World Neurol. 1962;3:1493-5.
Dourmishev LA, Dourmishev AL, Schwartz RA. Dermatomyositis: cutaneous manifestations of its variants. Int J Dermatol. 2002;41(10):625-30.
Gordon P, Creamer D. Dermatomyositis. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s Textbook of Dermatology. 8th ed. UK: Wiley- Blackwell.2010;1497-1509.
Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis : a population- based study. Lancet. 2001;357(9250):96-100.
Chakroun A, Guigay J, Lusinchi A, Marandas P, Janot F, Hartl DM. Paraneoplastic dermatomyositis ccompanying nasopharyngeal carcinoma: diagnosis, treatment and prognosis. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:127-31.
Gupta V, Seshadri D, Vijay MK, Sahai P, Gupta S. Dermatomyositis and nasopharyngeal carcinoma in an Indian patient. Indian J Dermatol Venereol Leprol. 2014;80(2):167-8.
Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P, et al. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol. 2002;138(7):885-90.
Wolff M, Mancuso C, Lal K, Dicostanzo D, Gropper C. Paraneoplastic dermatomyositis with cutaneous and myopathic disease responsive to adrenocorticotrophic hormone therapy. J Clin Aesthet Dermatol. 2017;10(1):57-62.
